Grifols adds to Gotham City response, will initiate legal action

Grifols said that as a continuation of the communications filed yesterday by the company as a consequence of the Gotham City Research report, the company wants to inform of the following: Thomas Glanzmann, the current Chief Executive Officer and Executive Chairman of the Board, joined the board in 2006. “He has since then been an important contributor in the Company’s growth and development. The Board of the Company fully supports Mr. Thomas Glanzmann since he was appointed to his positions”; All relevant transactions described in the mentioned report published yesterday have been unanimously approved by the board and its various committees, and they include all the necessary supporting information and documentation, including valuations and third-party opinions; The Gotham report questions the price paid for donor center acquisitions, “which is difficult to understand without having the adequate information. As with the purchase of any business, the price paid is not only the price of the assets, but also their ability to generate profit.” The company will initiate legal actions against Gotham City Research “for the significant financial and reputational damage caused to the Company and to all its stakeholders, as well as creating great concerns among patients and donors.”